Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 821,779 |
|
|||||
| News | - | ||||||
| Day High | 16.60 | Low High |
|||||
| Day Low | 16.02 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovoCure Ltd | NVCR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.28 | 1.74% | 16.41 | 19:59:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.22 | 16.02 | 16.60 | 16.47 | 16.13 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,467 | 821,779 | $ 16.28 | $ 13,378,353 | - | 10.87 - 83.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:25 | 30 | $ 16.23 | USD |
NovoCure (NVCR) Options Flow Summary
NovoCure Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.76B | 107.09M | - | 509.34M | -207.04M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NovoCure News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVCR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.65 | 16.60 | 14.31 | 15.59 | 1,095,463 | 1.76 | 12.01% |
| 1 Month | 14.01 | 16.60 | 11.70 | 13.33 | 1,098,447 | 2.40 | 17.13% |
| 3 Months | 15.71 | 18.04 | 11.70 | 14.45 | 1,321,383 | 0.70 | 4.46% |
| 6 Months | 11.46 | 18.04 | 10.87 | 14.00 | 1,344,473 | 4.95 | 43.19% |
| 1 Year | 70.85 | 83.60 | 10.87 | 23.93 | 1,535,560 | -54.44 | -76.84% |
| 3 Years | 190.45 | 232.76 | 10.87 | 58.34 | 948,612 | -174.04 | -91.38% |
| 5 Years | 49.79 | 232.76 | 10.87 | 75.92 | 939,437 | -33.38 | -67.04% |
NovoCure Description
| NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. |
